AN EXPERIMENTAL therapy has dramatically extended the lives of mice infected with prions, which cause conditions like Creutzfeldt-Jakob disease (CJD). The news, announced by biotech firm Sangamo Therapeutics, boosts hopes of developing treatments for these conditions.
展开▼